Insufficient scRNA-seq data for expression of UGT2B28 at single-cell level.
Insufficient scRNA-seq data for expression of UGT2B28 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 67% | 46.48 | 14 / 21 | 18% | 0.72 | 92 / 504 |
liver | 69% | 4.67 | 155 / 226 | 9% | 0.30 | 37 / 406 |
breast | 36% | 26.48 | 165 / 459 | 17% | 8.26 | 195 / 1118 |
kidney | 43% | 2.35 | 38 / 89 | 5% | 0.22 | 42 / 901 |
prostate | 44% | 6.26 | 109 / 245 | 2% | 0.10 | 12 / 502 |
spleen | 27% | 0.84 | 65 / 241 | 0% | 0 | 0 / 0 |
lung | 20% | 0.80 | 118 / 578 | 5% | 0.18 | 58 / 1155 |
stomach | 24% | 0.90 | 86 / 359 | 1% | 0.04 | 4 / 286 |
esophagus | 21% | 1.22 | 300 / 1445 | 2% | 0.04 | 3 / 183 |
skin | 21% | 8.95 | 381 / 1809 | 0% | 0 | 0 / 472 |
peripheral blood | 18% | 0.54 | 164 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 16% | 0.34 | 7 / 45 |
intestine | 13% | 0.43 | 121 / 966 | 1% | 0.02 | 3 / 527 |
pancreas | 6% | 0.15 | 20 / 328 | 3% | 0.52 | 6 / 178 |
uterus | 6% | 0.17 | 10 / 170 | 2% | 0.08 | 9 / 459 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.10 | 2 / 29 |
thymus | 5% | 0.15 | 31 / 653 | 1% | 0.05 | 5 / 605 |
ovary | 3% | 0.06 | 5 / 180 | 0% | 0.00 | 1 / 430 |
blood vessel | 3% | 0.07 | 37 / 1335 | 0% | 0 | 0 / 0 |
heart | 2% | 0.05 | 17 / 861 | 0% | 0 | 0 / 0 |
adipose | 2% | 0.05 | 23 / 1204 | 0% | 0 | 0 / 0 |
muscle | 2% | 0.07 | 15 / 803 | 0% | 0 | 0 / 0 |
brain | 2% | 0.06 | 49 / 2642 | 0% | 0 | 0 / 705 |
adrenal gland | 1% | 0.03 | 3 / 258 | 0% | 0.01 | 1 / 230 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0052697 | Biological process | xenobiotic glucuronidation |
GO_0008202 | Biological process | steroid metabolic process |
GO_0052695 | Biological process | cellular glucuronidation |
GO_0008210 | Biological process | estrogen metabolic process |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005640 | Cellular component | nuclear outer membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0015020 | Molecular function | glucuronosyltransferase activity |
Gene name | UGT2B28 |
Protein name | UDP-glucuronosyltransferase 2B28 (UDPGT 2B28) (UGT2B28) (EC 2.4.1.17) |
Synonyms | |
Description | FUNCTION: [Isoform 1]: UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile . Essential for the elimination and detoxification of drugs, xenobiotics and endogenous compounds . Catalyzes the glucuronidation of endogenous steroid hormones such as androgens (androsterone, 3alpha-androstanediol) and estrogens (estradiol, estrone) . Catalyzes the glucuronidation of bile acid substrates, which are natural detergents for dietary lipids absorption . Displays glucuronidation activity toward the phenolic compounds eugenol . .; FUNCTION: [Isoform 2]: Lack UDP-glucuronosyltransferase (UGT) activity. . |
Accessions | Q9BY64 ENST00000335568.10 [Q9BY64-1] ENST00000511240.1 [Q9BY64-2] |